VCYT(Veracyte, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $219.51M | $296.54M | $361.05M | $445.76M | $517.14M |
| 毛利润 | — | $175.68M | $229.68M | $298.14M | $362.53M |
| 营业利润 | −$81.90M | −$41.08M | −$85.80M | $16.14M | $57.78M |
| 净利润 | −$75.56M | −$36.56M | −$74.40M | $24.14M | $66.35M |
| 经营现金流 | −$31.62M | $7.54M | $44.22M | $75.10M | $136.31M |
| 自由现金流 | −$37.00M | −$1.01M | $34.26M | $63.81M | $126.63M |
| 摊薄每股收益 | $-1.11 | $-0.51 | $-1.02 | $0.31 | $0.82 |